A detailed history of Clari Vest Asset Management LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 20,239 shares of BPMC stock, worth $1.91 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
20,239
Previous 20,239 -0.0%
Holding current value
$1.91 Million
Previous $2.18 Million 14.21%
% of portfolio
0.19%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$85.18 - $108.78 $1,533 - $1,958
18 Added 0.09%
20,239 $2.18 Million
Q1 2024

May 06, 2024

SELL
$73.17 - $99.79 $7,682 - $10,477
-105 Reduced 0.52%
20,221 $1.92 Million
Q4 2023

Feb 13, 2024

SELL
$43.96 - $92.84 $62,027 - $130,997
-1,411 Reduced 6.49%
20,326 $1.87 Million
Q3 2023

Nov 13, 2023

BUY
$46.9 - $66.0 $938 - $1,320
20 Added 0.09%
21,737 $1.09 Million
Q2 2023

Aug 14, 2023

SELL
$42.2 - $66.37 $139,386 - $219,220
-3,303 Reduced 13.2%
21,717 $1.37 Million
Q1 2023

May 08, 2023

BUY
$37.97 - $50.0 $531 - $700
14 Added 0.06%
25,020 $1.13 Million
Q4 2022

Feb 14, 2023

SELL
$41.06 - $66.48 $3,243 - $5,251
-79 Reduced 0.31%
25,006 $1.1 Million
Q3 2022

Nov 10, 2022

SELL
$49.93 - $77.7 $242,709 - $377,699
-4,861 Reduced 16.23%
25,085 $1.65 Million
Q2 2022

Aug 12, 2022

SELL
$45.23 - $70.15 $235,195 - $364,780
-5,200 Reduced 14.8%
29,946 $1.51 Million
Q1 2022

May 04, 2022

SELL
$54.1 - $110.08 $210,070 - $427,440
-3,883 Reduced 9.95%
35,146 $2.25 Million
Q4 2021

Feb 14, 2022

SELL
$94.25 - $115.99 $1.41 Million - $1.73 Million
-14,925 Reduced 27.66%
39,029 $4.18 Million
Q3 2021

Nov 08, 2021

BUY
$80.98 - $109.47 $42,190 - $57,033
521 Added 0.98%
53,954 $5.55 Million
Q2 2021

Aug 09, 2021

BUY
$82.78 - $101.0 $4.42 Million - $5.4 Million
53,433 New
53,433 $4.7 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.65B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.